Amyloid β25–35 induced ROS-burst through NADPH oxidase is sensitive to iron chelation in microglial Bv2 cells

Microglia-mediated neurotoxicity: uncovering the molecular mechanisms

Block, M. L., Zecca, L., & Hong, J.-S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2038 · Cited by 4,110 · see citing works

Copper, iron and zinc in Alzheimer's disease senile plaques

Lovell, M. A., Robertson, J. D., Teesdale, W. J., Campbell, J. L., & Markesbery, W. R. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00092-6 · Cited by 2,120 · see citing works

Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides

Yankner, B. A., Duffy, L. K., & Kirschner, D. A. (1990) · Science · doi:10.1126/science.2218531 · Cited by 1,975 · see citing works

Iron accumulation in Alzheimer disease is a source of redox-generated free radicals

Smith, M. A., Harris, P. L. R., Sayre, L. M., & Perry, G. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9866 · Cited by 1,357 · see citing works

Iron metabolism and toxicity

Papanikolaou, G., & Pantopoulos, K. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.06.021 · Cited by 1,070 · see citing works

The labile iron pool: characterization, measurement, and participation in cellular processes1 1This article is part of a series of reviews on “Iron and Cellular Redox Status.” The full list of papers may be found on the homepage of the journal.

Kakhlon, O., & Cabantchik, Z. I. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)01006-7 · Cited by 839 · see citing works

Inflammatory processes in Alzheimer's disease

Heneka, M. T., & O'Banion, M. K. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.11.017 · Cited by 782 · see citing works

The redox chemistry of the Alzheimer's disease amyloid β peptide

Smith, D. G., Cappai, R., & Barnham, K. J. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.02.002 · Cited by 608 · see citing works

Therapeutics for Alzheimer's Disease Based on the Metal Hypothesis

Bush, A. I., & Tanzi, R. E. (2008) · Neurotherapeutics · doi:10.1016/j.nurt.2008.05.001 · Cited by 566 · see citing works

Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer’s disease: possible relation to oxidative stress.

Deibel, M. A., Ehmann, W. D., & Markesbery, W. R. (1996) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(96)00203-1 · Cited by 540 · see citing works

Structure and regulation of the neutrophil respiratory burst oxidase: comparison with nonphagocyte oxidases

Quinn, M. T., & Gauss, K. A. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0404216 · Cited by 480 · see citing works

Inflammation, microglia, and alzheimer's disease

Cameron, B., & Landreth, G. E. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.10.006 · Cited by 440 · see citing works

Metal dyshomeostasis and oxidative stress in Alzheimer’s disease

Greenough, M. A., Camakaris, J., & Bush, A. I. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.08.014 · Cited by 439 · see citing works

The toxicity in vitro of β-amyloid protein

Iversen, L. L., Mortishire‐Smith, R. J., Pollack, S. J., & Shearman, M. S. (1995) · Biochemical Journal · doi:10.1042/bj3110001 · Cited by 425 · see citing works

The crucial role of metal ions in neurodegeneration: the basis for a promising therapeutic strategy

Gaeta, A., & Hider, R. C. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706416 · Cited by 411 · see citing works

Fluorescence analysis of the labile iron pool of mammalian cells

Epsztejn, S., Kakhlon, O., Glickstein, H., Breuer, W., & Cabantchik, Z. I. (1997) · Analytical Biochemistry · doi:10.1006/abio.1997.2126 · Cited by 391 · see citing works

Metallostasis in Alzheimer's disease

Ayton, S., Lei, P., & Bush, A. I. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.10.558 · Cited by 354 · see citing works

Inflammation in Alzheimer's disease: Amyloid-β oligomers trigger innate immunity defence via pattern recognition receptors

Salminen, A., Ojala, J. O., Kauppinen, A., Kaarniranta, K., & Suuronen, T. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.01.001 · Cited by 350 · see citing works

Ribosomal RNA in Alzheimer Disease Is Oxidized by Bound Redox-active Iron

Honda, K., Smith, M. A., Zhu, X., Baus, D., Merrick, W. C., Tartakoff, A. M., Hattier, T., Harris, P. L., Siedlak, S. L., Fujioka, H., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500526200 · Cited by 280 · see citing works

In vivo conversion of racemized β‐amyloid ([ D ‐Ser26]Aβ1–40) to truncated and toxic fragments ([ D ‐Ser26]Aβ25–35/40) and fragment presence in the brains of Alzheimer's patients

Kubo, T., Nishimura, S., Kumagae, Y., & Kaneko, I. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10391 · Cited by 250 · see citing works

Role of reactive oxygen species in LPS‐induced production of prostaglandin E2in microglia

Wang, T., Qin, L., Liu, B., Liu, Y., Wilson, B. C., Eling, T. E., Langenbach, R. I., Taniura, S., & Hong, J. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02242.x · Cited by 218 · see citing works

Cellular management of iron in the brain

Connor, J. R., & Menzies, S. L. (1995) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(95)00206-h · Cited by 213 · see citing works

NADPH oxidases: novel therapeutic targets for neurodegenerative diseases

Gao, H., Zhou, H., & Hong, J. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.03.008 · Cited by 212 · see citing works

Metal ions, Alzheimer's disease and chelation therapy

Budimir, A. (2011) · Acta Pharmaceutica · doi:10.2478/v10007-011-0006-6 · Cited by 202 · see citing works

NADPH oxidase as a therapeutic target in Alzheimer's disease

Block, M. L. (2008) · BMC Neuroscience · doi:10.1186/1471-2202-9-s2-s8 · Cited by 202 · see citing works

Gp91 <i> ^phox </i> is the heme binding subunit of the superoxide-generating NADPH oxidase

Yu, L., Quinn, M. T., Cross, A. R., & Dinauer, M. C. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.7993 · Cited by 202 · see citing works

Gp91phox (NOX2) in classically activated microglia exacerbates traumatic brain injury

Dohi, K., Ohtaki, H., Nakamachi, T., Yofu, S., Satoh, K., Miyamoto, K., Song, D., Tsunawaki, S., Shioda, S., & Aruga, T. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-41 · Cited by 188 · see citing works

Novel multifunctional neuroprotective iron chelator‐monoamine oxidase inhibitor drugs for neurodegenerative diseases.<i>In vivo</i>selective brain monoamine oxidase inhibition and prevention of MPTP‐induced striatal dopamine depletion

Gal, S., Zheng, H., Fridkin, M., & Youdim, M. B. H. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03341.x · Cited by 185 · see citing works

Ultraviolet A radiation induces immediate release of iron in human primary skin fibroblasts: The role of ferritin

Pourzand, C., Watkin, R. D., Brown, J. E., & Tyrrell, R. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6751 · Cited by 176 · see citing works

Subcellular and metabolic examination of amyloid-β peptides in Alzheimer disease pathogenesis: Evidence for Aβ25–35

Kaminsky, Y. G., Marlatt, M. W., Smith, M. A., & Kosenko, E. A. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.09.005 · Cited by 165 · see citing works

Biosynthesis of the Phagocyte NADPH Oxidase Cytochromeb 558

Yu, L., Zhen, L., & Dinauer, M. C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.43.27288 · Cited by 162 · see citing works

Intramembrane proteolysis by presenilins

Steiner, H., & Haass, C. (2000) · Nature Reviews Molecular Cell Biology · doi:10.1038/35043065 · Cited by 161 · see citing works

The role of an astrocytic NADPH oxidase in the neurotoxicity of amyloid beta peptides

Abramov, A. Y., & Duchen, M. R. (2005) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2005.1766 · Cited by 158 · see citing works

Detection of reactive oxygen species derived from the family of NOX NADPH oxidases

Maghzal, G. J., Krause, K., Stocker, R., & Jaquet, V. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.09.002 · Cited by 151 · see citing works

Active Site Environment of Heme-Bound Amyloid β Peptide Associated with Alzheimer’s Disease

Pramanik, D., & Dey, S. G. (2010) · Journal of the American Chemical Society · doi:10.1021/ja1084578 · Cited by 151 · see citing works

Alzheimer's disease & metals: therapeutic opportunities

Kenche, V. B., & Barnham, K. J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01221.x · Cited by 144 · see citing works

Flow cytometry measurement of the labile iron pool in human hematopoietic cells

Prus, E., & Fibach, E. (2007) · Cytometry Part A · doi:10.1002/cyto.a.20491 · Cited by 129 · see citing works

Fibrillar beta-amyloid peptide Aβ1–40 activates microglial proliferation via stimulating TNF-α release and H2O2 derived from NADPH oxidase: a cell culture study

Jekabsone, A., Mander, P. K., Tickler, A. K., Sharpe, M. A., & Brown, G. C. (2006) · Journal of Neuroinflammation · doi:10.1186/1742-2094-3-24 · Cited by 127 · see citing works

Multi Target Neuroprotective and Neurorestorative Anti-Parkinson and Anti-Alzheimer Drugs Ladostigil and M30 Derived from Rasagiline

Youdim, M. B. H. (2013) · Experimental Neurobiology · doi:10.5607/en.2013.22.1.1 · Cited by 110 · see citing works

Ternary Complexes of Iron, Amyloid-β, and Nitrilotriacetic Acid: Binding Affinities, Redox Properties, and Relevance to Iron-Induced Oxidative Stress in Alzheimer’s Disease

Jiang, D., Li, X., Williams, R. S., Patel, S., Men, L., Wang, Y., & Zhou, F. (2009) · Biochemistry · doi:10.1021/bi900907a · Cited by 109 · see citing works

Chelation therapy for neurodegenerative diseases

Bolognin, S., Drago, D., Luigi Messori, A., & Zatta, P. F. (2009) · Medicinal Research Reviews · doi:10.1002/med.20148 · Cited by 97 · see citing works

Nanoparticle and Iron Chelators as a Potential Novel Alzheimer Therapy

Liu, G., Men, P., Perry, G. L., & Smith, M. A. (2009) · Methods in molecular biology · doi:10.1007/978-1-60327-029-8_8 · Cited by 95 · see citing works

Recent Insights into Interactions of Deferoxamine with Cellular and Plasma Iron Pools: Implications for Clinical Use

Porter, J. B., Rafique, R., Srichairatanakool, S., Davis, B. A., Shah, F., HAIR, T., & Evans, P. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1345.018 · Cited by 80 · see citing works

Rapid aggregation and assembly in aqueous solution of Aβ (25–35) peptide

Millucci, L., Raggiaschi, R., Franceschini, D., Terstappen, G. C., & Santucci, A. (2009) · Journal of Biosciences · doi:10.1007/s12038-009-0033-3 · Cited by 79 · see citing works

Activated microglia cause superoxide-mediated release of iron from ferritin

Yoshida, T., Tanaka, Μ., Sotomatsu, A., & Hirai, S. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11490-n · Cited by 78 · see citing works

Mitochondrial Ferritin Attenuates β -Amyloid-Induced Neurotoxicity: Reduction in Oxidative Damage Through the Erk/P38 Mitogen-Activated Protein Kinase Pathways

Wu, W.-S., Zhao, Y., Shi, Z.-H., Chang, S.-Y., Nie, G., Duan, X.-L., Zhao, S.-M., Wu, Q., Yang, Z.-L., Zhao, B.-L., et al. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4285 · Cited by 73 · see citing works

Iron Chelation Via Deferoxamine Exacerbates Experimental Salmonellosis Via Inhibition of the Nicotinamide Adenine Dinucleotide Phosphate Oxidase-Dependent Respiratory Burst

Collins, H. L., Kaufmann, S. H. E., & Schaible, U. E. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.7.3458 · Cited by 69 · see citing works

Subcellular distribution of desferrioxamine and hydroxypyridin‐4‐one chelators in K562 cells affects chelation of intracellular iron pools

Hoyes, K. P., & Porter, J. B. (1993) · British Journal of Haematology · doi:10.1111/j.1365-2141.1993.tb03184.x · Cited by 64 · see citing works

Iron Chelation Inhibits NF-κB–Mediated Adhesion Molecule Expression by Inhibiting p22 ^phox Protein Expression and NADPH Oxidase Activity

Li, L., & Frei, B. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000245820.34238.da · Cited by 49 · see citing works

Synthesis, physical–chemical characterisation and biological evaluation of novel 2-amido-3-hydroxypyridin-4(1H)-ones: Iron chelators with the potential for treating Alzheimer’s disease

Gaeta, A., Molina‐Holgado, F., Kong, X. L., Salvage, S., Fakih, S., Francis, P. T., Williams, R. J., & Hider, R. C. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.12.007 · Cited by 45 · see citing works

Prolonged Exposure to LPS Increases Iron, Heme, and p22 phox Levels and NADPH Oxidase Activity in Human Aortic Endothelial Cells

Li, L., & Frei, B. B. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.183210 · Cited by 41 · see citing works

Nanoparticle Delivery of Transition-Metal Chelators to the Brain: Oxidative Stress will Never See it Coming!

Bonda, D., Liu, G., Men, P., Perry, G. L., Smith, M. A., & Zhu, X. (2012) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152712799960709 · Cited by 39 · see citing works

NADPH oxidase inhibitor diphenyliodonium abolishes lipopolysaccharide‐induced down‐regulation of transferrin receptor expression in N2a and BV‐2 cells

Reis, K., Hälldin, J., Fernaeus, S. Z., Pettersson, C., & Land, T. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.21005 · Cited by 29 · see citing works

Correction to Mitochondrial Ferritin Attenuates β -Amyloid-Induced Neurotoxicity: Reduction in Oxidative Damage Through the Erk/P38 Mitogen-Activated Protein Kinase Pathways, Authored by Wu WS, Zhao YS, Shi ZH, Chang SY, Nie GJ, Duan XL, Zhao SM, Wu Q, Yang ZL, Zhao BL, and Chang YZ ( Antioxid Redox Signal 18: 158–169, 2013)

Wu, W.-S., Zhao, Y., Shi, Z.-H., Chang, S.-Y., Nie, G., Duan, X.-L., Zhao, S.-M., Wu, Q., Yang, Z.-L., Zhao, B.-L., et al. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5266 · Cited by 20 · see citing works

“Pumping iron”—how macrophages handle iron at the systemic, microenvironmental, and cellular levels

Nairz, M., Theurl, I., Swirski, F. K., & Weiss, G. (2017) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-017-1944-8 · Cited by 178 · see citing works

Iron and Ferroptosis as Therapeutic Targets in Alzheimer's Disease

Gleason, A. J., & Bush, A. I. (2020) · Neurotherapeutics · doi:10.1007/s13311-020-00954-y · Cited by 134 · see citing works

Treating Alzheimer's disease by targeting iron

Nikseresht, S., Bush, A. I., & Ayton, S. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14567 · Cited by 98 · see citing works

The Role of Microglia in Alzheimer’s Disease From the Perspective of Immune Inflammation and Iron Metabolism

Long, H.-Z., Zhou, Z.-W., Cheng, Y., Luo, H.-Y., Li, F.-J., Xu, S., & Gao, L.-C. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.888989 · Cited by 94 · see citing works

Hepcidin attenuates amyloid beta‐induced inflammatory and pro‐oxidant responses in astrocytes and microglia

Urrutia, P. J., Hirsch, É. C., González-Billault, C. E., & Núñez, M. T. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14005 · Cited by 66 · see citing works

The Role of Hypoxia-Inducible Factor 1 in Mild Cognitive Impairment

Iyalomhe, O., Swierczek, S. I., Enwerem, N. Y., Chen, Y., Adedeji, M. O., Allard, J. S., Ntekim, O. E., Johnson, S. M., Hughes, K., Kurian, P., et al. (2016) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-016-0440-6 · Cited by 64 · see citing works

ROS production and mitochondrial dysfunction driven by PU.1-regulated NOX4-p22phox activation in Aβ-induced retinal pigment epithelial cell injury

Sun, J., Chen, J., Li, T., Huang, P., Li, J., Shen, M., Gao, M., Sun, Y., Liang, J., Li, X., et al. (2020) · Theranostics · doi:10.7150/thno.48064 · Cited by 40 · see citing works

Lactoferrin improves cognitive function and attenuates brain senescence in aged mice

Zheng, J., Xie, Y., Li, F., Zhou, Y., Qi, L., Liu, L., & Chen, Z. (2019) · Journal of Functional Foods · doi:10.1016/j.jff.2019.103736 · Cited by 39 · see citing works

N-Adamantyl-4-methylthiazol-2-amine suppresses amyloid β-induced neuronal oxidative damage in cortical neurons

Cho, C. H., Kim, E.-A. L., Kim, J., Choi, S. Y., Yang, S.-J., & Cho, S. (2016) · Free Radical Research · doi:10.3109/10715762.2016.1167277 · Cited by 34 · see citing works

The role of microglia in neurodegenerative diseases: from the perspective of ferroptosis

Liu, Y.-J., Jia, G.-R., Zhang, S.-H., Guo, Y., Ma, X.-Z., Xu, H.-M., & Xie, J.-X. (2025) · Acta Pharmacologica Sinica · doi:10.1038/s41401-025-01560-4 · Cited by 29 · see citing works

Death-associated protein kinase 1 mediates interleukin-1β production through regulating inlfammasome activation in Bv2 microglial cells and mice

Song, L., Pei, L., Hu, L., Pan, S., Xiong, W., Liu, M., Wu, Y., Shang, Y., & Yao, S. (2018) · Scientific Reports · doi:10.1038/s41598-018-27842-y · Cited by 20 · see citing works

Ferroptosis in Alzheimer's Disease: The Regulatory Role of Glial Cells.

Xu, J., Shen, R., Qian, M., Zhou, Z., Xie, B.-Q., Jiang, Y., Yu, Y., & Dong, W. (2025) · Journal of Integrative Neuroscience · doi:10.31083/jin25845 · Cited by 22 · see citing works

Research progress on ferroptosis in the pathogenesis and treatment of neurodegenerative diseases

Wang, L., Fang, X., Ling, B., Wang, F., Xia, Y., Zhang, W., Zhong, T., & Wang, X. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1359453 · Cited by 18 · see citing works

Anthocyanin-Rich Fraction of Black Rice Bran Extract Protects against Amyloid β-Induced Oxidative Stress, Endoplasmic Reticulum Stress, and Neuronal Apoptosis in SK-N-SH Cells

Sivasinprasasn, S., Tocharus, J., Mahatheeranont, S., Nakrat, S., & Tocharus, C. (2024) · Pharmaceuticals · doi:10.3390/ph17081039 · Cited by 15 · see citing works

Anti-inflammatory and anti-oxidative effects of 3-(naphthalen-2-yl(propoxy)methyl)azetidine hydrochloride on β-amyloid-induced microglial activation

Yang, S.-J., Kim, J., Lee, S. E., Ahn, J., Choi, S. Y., & Cho, S. (2017) · BMB Reports · doi:10.5483/bmbrep.2017.50.12.189 · Cited by 12 · see citing works

Ferroptosis-Regulated Cell Death as a Therapeutic Strategy for Neurodegenerative Diseases: Current Status and Future Prospects

Zhang, J., Jia, X., Cao, Q., Chen, Y.-T., Tong, J., Lu, G., Li, D., Han, T., Zhuang, C., & Wang, P. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00406 · Cited by 11 · see citing works

Is there a place for iron chelation in HIV infection?

Boelaert, J. R., Weinberg, G. A., & Weinberg, E. D. (1995) · The Netherlands Journal of Medicine · doi:10.1016/0300-2977(96)80094-5

NADPH oxidase as a therapeutic target in Alzheimer's disease

Block, M. L. (2008) · BMC Neuroscience · doi:10.1186/1471-2202-9-s2-s8 · Cited by 202 · see citing works

The microglial NADPH oxidase complex as a source of oxidative stress in Alzheimer's disease.

Wilkinson, B. L., & Landreth, G. E. (2006) · Journal of Neuroinflammation · doi:10.1186/1742-2094-3-30 · Cited by 235 · see citing works

β-Amyloid Activates the O⨪2 Forming NADPH Oxidase in Microglia, Monocytes, and Neutrophils

Della Bianca, V., Dusi, S., Bianchini, E., Dal Prà, I., & Rossi, F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.22.15493 · Cited by 324 · see citing works

Oxidative Stress, Neuroinflammation, and NADPH Oxidase: Implications in the Pathogenesis and Treatment of Alzheimer’s Disease

Ganguly, U., Kaur, U., Chakrabarti, S. S., Sharma, P., Agrawal, B. K., Saso, L., & Chakrabarti, S. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/7086512 · Cited by 150 · see citing works